ANLN and PDGFD were significantly upregulated in CRC with lymph node metastases when compared to those without lymph node metastases and can be considered as potential biomarkers for metastases in CRC. This evidence concerns the gene PDGFD and metastatic malignant neoplasm in the lymph nodes.